Pipethiaden
Подписчиков: 0, рейтинг: 0
| Clinical data | |
|---|---|
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C18H19NS2 |
| Molar mass | 313.48 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Pipethiaden is a benzothiepin-based drug candidate that was at one time studied as a potential preventive to reduce the frequency of recurrent migraine headaches. It also has some activity as an antihistamine acting mainly at the 5-HT2A and 5HT2C receptors.
|
Antimigraine preparations (N02C)
| |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Analgesic/abortive |
|
||||||||||||||||
| Prophylactic |
|
||||||||||||||||
| |||||||||||||||||